Open AccessA Randomized Control Trial of Ravulizumab for Treatment of Patients With COVID-19 Infection and Kidney Injury
Author(s) -
Aliza Anwar Memon,
Hasban Ahmed,
Yi Li,
Janewit Wongboonsin,
Joshua Hundert,
Stefanie W. Benoit,
Advika Chaudhari,
Jawad Sher,
Pratima Ghimire,
Rebecca J. Hopkins,
Jay Patel,
Melinda Stegman,
Kenneth Lim,
Jamil Azzi,
Andrew M. Siedlecki
Publication year - 2022
Publication title -
kidney international reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.225
H-Index - 22
ISSN - 2468-0249
DOI - 10.1016/j.ekir.2022.09.003
Subject(s) - medicine , acute kidney injury , kidney disease , kidney , fibrin , covid-19 , randomized controlled trial , pathology , intensive care medicine , disease , immunology , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom